StonvexLoading…
StonvexStonvexStonvexCore line items from KYMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.21M | $47.07M | $78.59M | $46.83M |
Operating Income | $-349.40M | $-261.63M | $-165.53M | $-161.26M |
Net Income | $-311.35M | $-223.86M | $-146.96M | $-154.81M |
EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 |
Total Assets | $1.74B | $978.03M | $575.76M | $603.13M |
Total Liabilities | $163.15M | $142.42M | $180.79M | $112.98M |
Cash & Equivalents | $357.01M | $120.26M | $109.97M | $68.39M |
Free Cash Flow OCF − CapEx | $-234.34M | $-207.34M | $-137.31M | $-155.92M |
Shares Outstanding | 81.32M | 64.89M | 55.59M | 55.04M |